Loading...
Market
What will be the outcome of the investigation into Leon Wang by end of 2024?
3
Resolution / Starting Odds
Cleared of all charges • 25%
Fined or penalized • 25%
Criminal charges filed • 25%
Other outcome • 25%
Official statements from Chinese authorities or AstraZeneca
Story
AstraZeneca's China President and EVP Leon Wang Under Investigation; Shares Drop 3.5%
Oct 30, 2024, 02:00 PM
AstraZeneca announced at 9:00am that its China President and Executive Vice President of International, Leon Wang, is currently under investigation by Chinese authorities and is cooperating with the inquiry. The company's China operations will continue under the leadership of the current general manager. Following the announcement, AstraZeneca's shares dropped by 3.5%.
View original story
Similar markets
Cleared of charges • 25%
Charged and dismissed • 25%
Charged but retains position • 25%
Investigation inconclusive • 25%
Charged with corruption • 25%
Cleared of charges • 25%
Resigns without charges • 25%
Investigation inconclusive • 25%
All arrested • 25%
Some arrested • 25%
None arrested • 25%
Unknown outcome • 25%
Company fined • 25%
Company executives jailed • 25%
Company cleared of charges • 25%
No legal actions taken • 25%
No action taken • 25%
Formal charges filed • 25%
Deportation or expulsion • 25%
Other outcome • 25%
Guilty Plea • 25%
Not Guilty Plea • 25%
Case Dismissed • 25%
Other Outcome • 25%
Guilty plea • 25%
Not guilty plea • 25%
Case dismissal • 25%
Trial scheduled • 25%
No further action • 25%
Further investigation • 25%
Legal action against associates • 25%
Yang Tengbo extradited • 25%
Attacker charged with attempted murder • 25%
Attacker charged with lesser crime • 25%
Attacker found not guilty • 25%
Case unresolved by end of 2024 • 25%
Guilty • 25%
Not Guilty • 25%
Case Dismissed • 25%
Plea Deal • 25%
Convicted • 25%
Acquitted • 25%
Plea Bargain • 25%
Case Dismissed • 25%